Our Innovation
Our Innovation addresses novel solutions for drug discovery and development that have an impact on companies, research institutes, and Health Care. We address your needs by leveraging state-of-the-art capabilities and technologies to develop services that can support your drug development programs.
To be successful in developing a drug candidate, mode of action patterns needs to be resolved, therapeutic modalities needs to be tailored to provide optimal treatment and therapeutic outcomes have to be monitored.
We strive to develop “best in class” solutions and are are currently running two ambitious R&D programs within:
- Cell Models & Assay Development
- Drug Candidate Development & Formulation
For further information, please contact CSO Christian Clausen by email or CBO Jette Asboe Lassen by email.
To be successful in developing a drug candidate, mode of action patterns needs to be resolved, therapeutic modalities needs to be tailored to provide optimal treatment and therapeutic outcomes have to be monitored.
We strive to develop “best in class” solutions and are currently running two ambitious R&D programs within:
- Cell Models & Assay Development
- Drug Candidate Development & Formulation
For further information, please contact CSO Christian Clausen by email or CBO Jette Asboe Lassen by email.
Bioneer develop cutting-edge cell models and assays with focus on the following areas: CNS, Cancer, & Immunology.
Bioneer develops solutions for manufacturing of recombinant proteins and solutions for pre- formulation covering proteins, peptides, small molecules and cell therapies.
